← Eichor
Study identifier: NCT04851509 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Static Helical Screw Locking of Pertrochanteric Femur Fractures Using the TFN-A

Condition: Pertrochanteric Fracture  ·  Sponsor: Fraser Orthopaedic Research Society

PhaseNA
Planned participants218
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The study will investigate the shortening and collapse of pertrochanteric fractures following surgical management with the TFN-Advanced nailing system. The focus will be on comparing radiographic assessments of nails which have been statically locked versus dynamically locked. This is a randomized control study with the initial invention being randomized to either statically locking or dynamically locking. For a two-month period, all eligible patients will receive the randomized allocated treatment, then treatment will switch to the alternate treatment for the next two months and will continue to alternate treatments for two-month periods until study enrollment has completed.

This description comes directly from the study's public registry record.

Talk to the study team

Kyrsten Butterfield, BSc  ·  604-553-3247  ·  kyrsten.butterfield@fraserhealth.ca

Always discuss trial participation with your own doctor first.

Locations (1)

Royal Columbian Hospital/Fraser Health AuthorityNew Westminster, British Columbia, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04851509